Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | 2-Chloroquinoline | HCID 11928 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Solvent | Ethylene Glycol | HCID 174 | — |
| Product | Quipazine | HCID 5011 | 102.2% |
Reaction Steps
To a solution formed by dissolving 4.31 g of anhydrous piperazine in 30 ml of ethylene glycol, 818 mg of 2-chloroquinoline was added, and stirred at 140° C. for 2 hours. After cooling the reaction mixture, saturated aqueous sodium hydrogencarbonate solution was added, followed by extraction with chloroform. The organic layer was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified on silica gel column chromatography (chloroform:methanol=2:1) to provide 1.09 g (100%) of 2-piperazin-1-ylquinoline.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07799775B2 |
|---|
| Source dataset | uspto-grants-2010_09 |
|---|
| ORD ID | ord-4fa9ca7447264c219f8376d75b571aba |
|---|
| Source note | uspto-grants-2010_09 |
|---|